These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20367907)

  • 41. High mortality from respiratory failure secondary to swine-origin influenza A (H1N1) in South Africa.
    Koegelenberg CF; Irusen EM; Cooper R; Diacon AH; Taljaard JJ; Mowlana A; von Groote-Bidlingmaier F; Bolliger CT
    QJM; 2010 May; 103(5):319-25. PubMed ID: 20219780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of extracorporeal technology during pandemics: ethical and staffing considerations.
    Kissoon N; Bohn D
    Pediatr Crit Care Med; 2010 Nov; 11(6):757-8. PubMed ID: 21057269
    [No Abstract]   [Full Text] [Related]  

  • 43. Simulation-based training of extracorporeal membrane oxygenation during H1N1 influenza pandemic: the Italian experience.
    Brazzi L; Lissoni A; Panigada M; Bottino N; Patroniti N; Pappalardo F; Gattinoni L
    Simul Healthc; 2012 Feb; 7(1):32-4. PubMed ID: 22293665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan.
    Takeda S; Kotani T; Nakagawa S; Ichiba S; Aokage T; Ochiai R; Taenaka N; Kawamae K; Nishimura M; Ujike Y; Tajimi K;
    J Anesth; 2012 Oct; 26(5):650-7. PubMed ID: 22618953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracorporeal membrane oxygenation support in management of severe respiratory failure secondary to 2009 influenza A(H1N1) virus.
    Yan TD; Poh CL; Martens-Nielsen J
    Chest; 2010 Aug; 138(2):455; author reply 455-6. PubMed ID: 20682540
    [No Abstract]   [Full Text] [Related]  

  • 46. A[H1N1] flu and refractory hypoxaemia: is extracorporeal lung support the holy grail?
    Veenith TV; Rana M; Ercole A; Gunning K; Mahroof R
    Thorax; 2011 Sep; 66(9):836-7. PubMed ID: 21515552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracorporeal membrane oxygenation (ECMO) in cystic fibrosis.
    Shah N; Perrin F
    Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():26-8. PubMed ID: 24846285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of extracorporeal life support in adults with severe acute respiratory failure.
    Rehder KJ; Turner DA; Cheifetz IM
    Expert Rev Respir Med; 2011 Oct; 5(5):627-33. PubMed ID: 21955233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Point: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence?
    Park PK; Dalton HJ; Bartlett RH
    Chest; 2010 Oct; 138(4):776-8. PubMed ID: 20923796
    [No Abstract]   [Full Text] [Related]  

  • 50. Justification for chest physiotherapy during ultra-protective lung ventilation and extra-corporeal membrane oxygenation: a case study.
    Cork G; Barrett N; Ntoumenopoulos G
    Physiother Res Int; 2014 Jun; 19(2):126-8. PubMed ID: 23955843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ECMO and the elephant in the corner.
    Chan V; Rubens F
    Perfusion; 2009 Jul; 24(4):223-4. PubMed ID: 19948750
    [No Abstract]   [Full Text] [Related]  

  • 52. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course.
    Töpfer L; Menk M; Weber-Carstens S; Spies C; Wernecke KD; Uhrig A; Lojewski C; Jörres A; Deja M
    J Crit Care; 2014 Jun; 29(3):340-6. PubMed ID: 24508203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Counterpoint: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence?
    Morris AH; Hirshberg E; Miller RR; Statler KD; Hite RD
    Chest; 2010 Oct; 138(4):778-81; discussion 782-4. PubMed ID: 20923797
    [No Abstract]   [Full Text] [Related]  

  • 54. Logistics and safety of extracorporeal membrane oxygenation in medical retrieval.
    Burns BJ; Habig K; Reid C; Kernick P; Wilkinson C; Tall G; Coombes S; Manning R
    Prehosp Emerg Care; 2011; 15(2):246-53. PubMed ID: 21294633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First application of a new portable, miniaturized system for extracorporeal membrane oxygenation.
    Müller T; Philipp A; Lubnow M; Weingart C; Pfeifer M; Riegger GA; Schmid C
    Perfusion; 2011 Jul; 26(4):284-8. PubMed ID: 21558298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparing for the Sickest Patients With 2009 Influenza A(H1N1).
    White DB; Angus DC
    JAMA; 2009 Nov; 302(17):1905-6. PubMed ID: 19822629
    [No Abstract]   [Full Text] [Related]  

  • 57. Impact of the 2013/2014 influenza season on extracorporeal membrane oxygenation programs in the United States.
    Palanzo DA; Wise RK; Baer LD
    Artif Organs; 2014 Nov; 38(11):909-13. PubMed ID: 25402572
    [No Abstract]   [Full Text] [Related]  

  • 58. Reducing time on for extra-corporeal membrane oxygenation for adults with H1N1 pneumonia with the use of the Volume Diffusive Respirator.
    Michaels AJ; Hill JG; Long WB; Sperley BP; Young BP; Park PK; Rycus PT; Bartlett RH
    Am J Surg; 2013 May; 205(5):500-4. PubMed ID: 23592155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracorporeal Life Support for severe respiratory failure with special reference to the influenza H1N1 pandemic.
    Holzgraefe B
    Acta Anaesthesiol Scand; 2017 Feb; 61(2):259-260. PubMed ID: 28066903
    [No Abstract]   [Full Text] [Related]  

  • 60. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic.
    Mitchell MD; Mikkelsen ME; Umscheid CA; Lee I; Fuchs BD; Halpern SD
    Crit Care Med; 2010 Jun; 38(6):1398-404. PubMed ID: 20400902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.